Canwen Jiang
11Patents
4h-index
11Co-inventors
57Inventor score
Filing activity: Feb 27, 1997 → May 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8716327B2 | Methods of treating fatty liver disease | Human Necessities | 43 | Active |
| US9834604B2 | Inhibitors of T-cell activation | Chemistry; Metallurgy | 20 | Active |
| US8759501B2 | Oligosaccharides comprising an aminooxy group and conjugates thereof | Chemistry; Metallurgy | 8 | Active |
| US9469850B2 | Oligosaccharides comprising an aminooxy group and conjugates thereof | Chemistry; Metallurgy | 5 | Active |
| US10907142B2 | Oligosaccharides comprising an aminooxy group and conjugates thereof | Chemistry; Metallurgy | 4 | Active |
| US5985824A | Methods and compositions for treating cystic fibrosis | Human Necessities | 3 | Expired |
| US9556155B2 | Methods of treating fatty liver disease | Human Necessities | 3 | Active |
| US6323191A | Small molecule chloride transport | Human Necessities | 2 | Expired |
| US5834421A | Methods and compositions for treating cystic fibrosis | Human Necessities | 1 | Expired |
| US11028170B2 | Inhibitors of T-cell activation | Chemistry; Metallurgy | 0 | Active |
| US12043665B2 | Inhibitors of T-cell activation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.